Silo Pharma
Manufacturing · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
677 N Washington Blvd, Sarasota, Florida...Phone Number
(718) 400-9031Website
www.silopharma.comRevenue
<$5 MillionStock Symbol
SILOIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Silo Pharma
Silo Pharma Inc. is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including PTSD, stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. Silo focuses on developing novel therapies that are conventional drugs and psychedelic formulations.Explore more
Silo Pharma Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Silo Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Silo Pharma launches new products
Silo Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Silo Pharma had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Silo Pharma
Funding: Get notified immidiatlly once Silo Pharma has new funding data
Earning: See what the market has to say on Silo Pharma recently announced quarterly report
Check if Silo Pharma has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Silo Pharma is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Silo Pharma
Compare insights from companies similar to Silo Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Silo Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Silo Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Silo Pharma.
Silo Pharma financials insights
Gather financial insights about Silo Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Share Placement
$4.3M
2026
Stock/Share Issuance
$4M
Silo Pharma Tech Stack
A closer look at the technologies used by Silo Pharma
See more technologies
Most Recent Scoops
Person-Based
Product Launch, Pharmaceuticals
Funding
Funding
Person-Based
Cloud, Partnership, Artificial Intelligence
Person-Based
Partnership, Artificial Intelligence
Project
Product Development, Product Management, Intellectual Property, Legal Affairs, Pharmaceuticals
Silo Pharma News & Media
Silo Pharma to Highlight Patented Nose-to-Brain Drug Delivery Technology for PTSD at 2026 Nasal Innovation Forum
SARASOTA, FLA., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Silo Pharma (Nasdaq: SILO) (“Silo” or “the Company”), ”), a developmental-stage biopharmaceutical company focused on novel therapeutics and drug delivery systems with a wholly owned managed AI agent platform, today announced that company representatives will participate in the upcoming IPAC-RS 2026 Nasal Innovation Forum to be held September 16-17, 2026, in Jersey City, New Jersey.Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment
Follows recent European patent grant and coverage in multiple international markets as Silo continues to strengthen licensed IP portfolio for lead therapeutic programSilo Pharma Granted European Patent Covering Novel PTSD Therapy
Patent strengthens global IP protection for novel treatment approach designed to prevent stress-induced psychiatric disorders before symptoms developSilo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform
Collaboration supports development of a next-generation AWS-native platform designed to accelerate commercialization, scalability and enterprise adoption
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Silo Pharma
Sign Up For FreeTo access detailed company insights
Silo Pharma Inc. is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including PTSD, stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. Silo focuses on developing novel therapies that are conventional drugs and psychedelic formula... Read More
